Metastatic liver cancer patient registry from multiple Chinese centers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry gathers standardized, large-scale clinical data from multiple Chinese centers about patients with metastatic liver cancer. It records demographics, primary tumor features, systemic and local treatments, and outcomes to describe clinical patterns and prognostic factors. Data will be used to support high-quality real-world studies and evidence-based management of metastatic liver cancer. Participants include adults with confirmed liver metastases who consent and have complete baseline data, excluding primary liver cancers and those in other interventional trials. The study is led by Anhui Provincial Hospital with collaboration from several affiliated hospitals.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Patients with histologically or radiologically confirmed metastatic liver cancer.
2. Age ≥ 18 years.
3. Patients who have voluntarily signed the informed consent form.
4. Patients with complete baseline clinical data.

Exclusion Criteria:

1. Patients with primary liver cancer (e.g., hepatocellular carcinoma).
2. Patients with other malignant tumors that may interfere with the evaluation of liver metastasis.
3. Patients who have previously participated in other interventional clinical trials.
4. Patients with severe cognitive disorders or communication barriers that prevent informed consent.
5. Patients with incomplete or missing key clinical data.

Where it's running

• The First Affiliated Hospital of USTC (Anhui Provincial Hospital)
  Hefei, Anhui, China Recruiting
• The Affiliated Hospital of Qingdao University
  Qingdao, Shandong, China Recruiting
• The First Affiliated Hospital of Bengbu Medical University
  Bengbu, Anhui, China Not yet recruiting

Study contacts

• Study coordinator: Jizhou Wang, MD PhD
• Email: wangjoe@ustc.edu.cn
• Phone: +86 13836135864

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• CRISPR-edited donor liver transplant to reduce rejection

  This trial will try transplanting deceased-donor livers that have had key HLA genes removed with CRISPR to see if they cause less rejection in adults needing a liver transplant.

  Recruiting Phase 1/2 American Organ Transplant and Cancer Research Institute LLC · Beijing, Changping · NCT07053488

• Evaluating the impact of MR-guided radiation therapy on cancer treatment outcomes

  This study is testing how using a special type of radiation therapy with real-time imaging can improve treatment results and quality of life for adults with cancer.

  Recruiting at 14 sites UMC Utrecht · Pittsburgh, Pennsylvania and 17 other locations · NCT04075305

• DRAGON: International registry for patients who had combined portal and hepatic vein embolization before liver surgery

  This registry collects data on patients who had PVE/HVE before liver resection to see if it helps liver regeneration and what factors relate to outcomes.

  Recruiting at 30 sites Maastricht University Medical Center · Chicago, Illinois and 30 other locations · NCT07717437

• MRI-guided adaptive single-session radiation for liver tumors (SABR)

  This trial will test a single-session, MRI-guided adaptive high-dose radiation (SABR) for adults with primary or metastatic liver tumors to see if on-table MRI planning and replanning can treat tumors without a separate simulation visit.

  Recruiting Phase 2 Stanford University · Palo Alto, California · NCT07223307

• Histotripsy plus chemotherapy versus chemotherapy alone for colorectal cancer spread to the liver

  This trial will test whether adding noninvasive histotripsy to standard chemotherapy helps people with unresectable, liver‑confined colorectal cancer metastases stay free of disease progression longer.

  Recruiting Case Comprehensive Cancer Center · Cleveland, Ohio · NCT07044362

• Assessing blood biomarkers and MRI for liver cancer patients undergoing radiation therapy

  This study is testing if using special MRI scans and blood tests can help doctors keep track of liver health in patients with liver cancer who are getting radiation therapy.

  Recruiting Montefiore Medical Center · The Bronx, New York · NCT06899152

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.